Check out our solutions and see what we can offer depending on the animal species
Autogenous vaccine: An inactivated immunological veterinary medicinal product that is manufactured from pathogens and antigens obtained from one or more animals in an epidemiological unit and used for the treatment of such animal(s) in the same epidemiological unit or for the treatment of one or more animals in a unit for which an epidemiological link has been confirmed.
Definition of autovaccine given in: Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC.
Manufactured on-demand and under veterinary prescription.
Made out of recently isolated pathogens from a specific farm.
Destined to a specific farm, or various farms if related epidemiologically.
Constantly updated.
Inactivated, and therefore very safe.
When there is no registered vaccine marketed for that animal species and indication.
When commercial vaccine is not available.
When existing commercial vaccines do not cover the antigenic variants (serotypes, virulence factors, etc.) present on the farm.
When lack of efficacy of the commercial vaccine has been demonstrated.
Presence of sick animals with obvious clinical signs: the veterinarian makes a clinical diagnosis
Sampling: sending to the laboratory
Laboratory diagnosis: differential diagnosis, isolation of strains and their characterisation
Autogenous vaccine design: define which strains, serotypes, etc. are included.
Order: always under veterinary prescription
Manufacturing: following standardized production protocols
Quality control: composition, inactivation and sterility of the final injectable product are controlled
Shipping and application: shipped to farm, owner or veterinarian
EXOPOL: Autorized laboratory (REG No. 235/50/015-AV)
Registered veterinarian
Diagnostic laboratory
Autogenous vaccines producer
